Frequency Therapeutics - Delisted Stock
Frequency Therapeutics is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Frequency Therapeutics was actively traded. Please check the stock traded under the symbol KRRO.
Frequency Therapeutics Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Frequency Therapeutics market risk premium is the additional return an investor will receive from holding Frequency Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Frequency Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Frequency Therapeutics' alpha and beta are two of the key measurements used to evaluate Frequency Therapeutics' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 4.24 | |||
| Standard Deviation | 5.68 | |||
| Variance | 32.24 | |||
| Risk Adjusted Performance | (0.10) |
Delisting Warning - FREQ
Frequency Therapeutics was delisted
| The entity Frequency Therapeutics with a symbol FREQ was delisted from NASDAQ Exchange. Please try Frequency Therapeutics with a symbol KRRO from now on. Check all delisted instruments accross multiple markets. |
Frequency Therapeutics Corporate Management
Elected by the shareholders, the Frequency Therapeutics' board of directors comprises two types of representatives: Frequency Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Frequency. The board's role is to monitor Frequency Therapeutics' management team and ensure that shareholders' interests are well served. Frequency Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Frequency Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| John LaMattina | Advisor Board | Profile | |
| David Lucchino | President, CoFounder | Profile | |
| James Abely | Associate Sec | Profile | |
| Christopher Loose | CoFounder Officer | Profile | |
| Jason Glashow | Sr Affairs | Profile | |
| William MD | VP Medicine | Profile | |
| Quentin McCubbin | Chief Officer | Profile |
Still Interested in Frequency Therapeutics?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Frequency Therapeutics information on this page should be used as a complementary analysis to other Frequency Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in Frequency Stock
If you are still planning to invest in Frequency Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Frequency Therapeutics' history and understand the potential risks before investing.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities |